We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical Efficacy and Safety of Octreotide (SMS201-995) in Terminally Ill Japanese Cancer Patients with Malignant Bowel Obstruction.
- Authors
Shima, Yasuo; Ohtsu, Atshushi; Shirao, Kuniaki; Sasaki, Yasutsuna
- Abstract
Objective: In patients with advanced cancer, malignant bowel obstruction (MBO) causes gastrointestinal symptoms such as nausea and vomiting leading to severely impaired oral food intake. Thus, MBO markedly diminishes the quality of life (QOL) of these patients because placement of a nasogastric tube becomes necessary. Many studies have shown that octreotide (SMS201–995; SMS), a synthetic analog of somatostatin, is effective for controlling the symptoms of MBO. This study was conducted to assess the efficacy and safety of 300-µg/day initial dose of SMS in Japanese patients with MBO and to investigate the clinical benefit of patients achieved by the improvement of nausea/vomiting based on subjective assessment.
- Publication
Japanese Journal of Clinical Oncology, 2008, Vol 38, Issue 5, p354
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyn035